Navigation Links
Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
Date:8/23/2007

Genetic Biomarker Portfolio to Have Important Role in Targeted Drug

Development, Dosing Determination, and Pharmacogenetic Testing

Purchase Expands European Presence, Advances PGxHealth Test

Commercialization and Broadens Geographic Reach of Cogenics'

Pharmacogenomics Services

NEWTON, Mass., Aug. 23 /PRNewswire-FirstCall/ -- Clinical Data, Inc. (Nasdaq: CLDA) announced today that it has acquired privately held Epidauros Biotechnologie AG of Bernried, Germany, in a cash transaction valued at 8.75 million euros (or approximately $11.84 million). Epidauros brings to Clinical Data an established portfolio of proprietary genetic biomarkers, expertise in genetic biomarker discovery, relationships with leading diagnostic companies, and a fast-growing pharmacogenomics services business.

Among the strategic assets acquired by Clinical Data in the transaction is a significant intellectual property portfolio that includes biomarkers in genes relating to prominent drug transporters such as MDR1(1), OCT1(2), MRP1(3), and important cytochrome P450 drug metabolizing genes, such as CYP2B6(4) and CYP2D6(5). MDR1 encodes P-glycoprotein, a key protein involved in drug transport that is known to modulate drug disposition. In addition, the genes CYP2B6, OCT1, and MRP1 are implicated in the absorption, distribution, and metabolism of many drugs that span a variety of therapeutic classes and indications, and are likely to be important in both response and safety profiles for these drugs.

Clinical Data's President and CEO, Drew Fromkin, said, "We are pleased to have completed this highly strategic transaction, which we believe will enhance Clinical Data's ability to b
'/>"/>

SOURCE Clinical Data, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. BioRobot MDx standardize your automated protocols in clinical laboratories
2. What patients want: A story of choice, clinical trials & evidence-based medicine
3. ZyStor seeks to raise $15M for clinical trials
4. Prodesse begins clinical trials for flu virus detection
5. ConjuGon raises $3.3 million to fund clinical trials
6. Cancer-fighting agent heads for clinical trials
7. Quintessence cancer treatment chosen for clinical studies
8. Third Wave reports clinical growth, continued loss
9. Childrens expanding use of Sunrise Clinical Manager
10. Life-sciences conference to feature novel research with clinical potential
11. $14 million grant to drive clinical research at UW
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)...  Indianapolis-based medical device manufacturer NICO Corporation is ... products including the BrainPath® and Myriad™ technologies offering ... abnormalities and then removing affected tissue. More than ... 50 institutions throughout the United States ... in 12 abstracts, three peer-reviewed publications, and seven ...
(Date:5/4/2015)... , May 4, 2015 Tobira Therapeutics, ... on the development and commercialization of novel treatments ... completion of its merger with Regado Biosciences, Inc. ... the closing of the merger, Tobira raised $40 ... new investors and all current Tobira institutional investors, ...
(Date:5/4/2015)... AVIV, Israel , May 4, 2015  Tikcro ... filed its annual report on Form 20-F for the ... Securities and Exchange Commission ("SEC"). The annual report on ... the development of antibodies in the area of cancer ... with superior qualities of high specificity and binding in ...
(Date:5/4/2015)... , May 4, 2015  RegeneRx Biopharmaceuticals, ... announced that an independent team of researchers from ... that Thymosin B4 (TB4) plays an important role ... wounds, induced in an experimental mouse model, by ... remodeling of damaged dermal tissue.  The research found ...
Breaking Biology Technology:NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions 2NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions 3Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 2Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 3Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 4Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 5Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 6Tikcro Technologies Files Annual Report on Form 20-F for the Year Ended December 31, 2014 2Researchers Report that Thymosin B4 has a Major Role in Dermal Burn Wound Healing 2Researchers Report that Thymosin B4 has a Major Role in Dermal Burn Wound Healing 3
... 29 Nastech,Pharmaceutical Company Inc. (Nasdaq: NSTK ... nine-month periods ended September 30, 2007. Revenue ... $1.9 million,compared to $5.5 million for the quarter ... of $4.8 million related to our Parathyroid Hormone,(PTH1-34) ...
... Oct. 29 /PRNewswire/ - N30 Pharma (N30), a,biopharmaceutical ... respiratory drugs that target endogenous,s-nitrosothiols, today announced a ... covering the respiratory use of a s-nitrosothiol drug,candidate. ... "I am extremely pleased to announce this ...
... LA JOLLA, Calif., Oct. 29 TorreyPines Therapeutics,Inc. (Nasdaq: ... President and,Chief Executive Officer of TorreyPines, will present at ... in New York on Monday,November 5th at 9:10 a.m., ... be available live. You can,access the webcast at: ...
Cached Biology Technology:Nastech Announces Third Quarter 2007 Financial Results 2Nastech Announces Third Quarter 2007 Financial Results 3Nastech Announces Third Quarter 2007 Financial Results 4Nastech Announces Third Quarter 2007 Financial Results 5Nastech Announces Third Quarter 2007 Financial Results 6
(Date:3/31/2015)...  Elephant Talk Communications Corp. (NYSE MKT: ETAK) ("Elephant ... Defined Network Architecture (ET Software DNA® 2.0) platforms and ... $20.4 million for the year ended December 31, 2014 ... year ended December 31, 2013. At ... its multi-year transition away from its legacy landline business ...
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... the "Global Gesture Recognition Market in Automotive Sector ... analysts forecast the Global Gesture Recognition market in Automotive ... the period 2013-2018. Gesture recognition is the ... different gestures of an individual. Gesture recognition technology can ...
(Date:3/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) has ... Market 2015-2019" report to their offering. ... grow at a CAGR of 23.5 percent over the ... scenario and the growth prospects of the Global Iris ... market size, the report considers the revenue generated from ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... grains with solubles (DDGS) to growing pigs, many questions are ... "Previous research shows that while the amount of energy ... lower digestibility of energy in DDGS than in corn," said ... Department of Animal Sciences. "Our goal was to find out ...
... University of Pennsylvania biologists studying human reproduction ... factor to the maternal age-associated increase in aneuploidy, ... during reproductive cell division. Using naturally aging ... of reproductive life is most likely caused by ...
... who develop life-threatening bacterial infections, or septicemia, with insulin ... infection, if results of a new preliminary study can ... online ahead of print in Diabetes Care ... oxidative stress in study participants who had been injected ...
Cached Biology News:Swine researchers seek answers to fiber's low digestibility 2Why the biological clock? Penn study says aging reduces centromere cohesion, disrupts reproduction 2Insulin may reduce several inflammatory factors induced by bacterial infection 2
... Introduction of a protein into cells permits ... signaling pathways, apoptotic pathways, and transcription factor-mediated ... studying the effects of a specific protein ... the protein directly into the cell. ProteoJuice ...
... SE flow cytometry system is the superior ... over 25 years, BD cell sorters have ... in leading university, pharmaceutical, and biotechnology research ... the research demands of today, we have ...
... is a microarray service provider ... academic researchers. We are a ... and we provide expression profiling ... arrays. Gene expression reports ...
... Control and regulate cell stretching or compression ... microscope stage. Computer controlled so you can ... the strain to produce 64 unique strain ... then the ST-150. Both models are compatible ...
Biology Products: